vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and TELOS CORP (TLS). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $46.8M, roughly 1.3× TELOS CORP). TELOS CORP runs the higher net margin — -34.9% vs -70.9%, a 36.1% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs 8.1%). TELOS CORP produced more free cash flow last quarter ($8.0M vs $-1.8M). Over the past eight quarters, TELOS CORP's revenue compounded faster (25.7% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.
CTKB vs TLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $46.8M |
| Net Profit | $-44.1M | $-16.3M |
| Gross Margin | 52.9% | 35.0% |
| Operating Margin | -9.0% | -39.6% |
| Net Margin | -70.9% | -34.9% |
| Revenue YoY | 8.1% | 77.4% |
| Net Profit YoY | -557.1% | -74.8% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $46.8M | ||
| Q3 25 | $52.3M | $51.4M | ||
| Q2 25 | $45.6M | $36.0M | ||
| Q1 25 | $41.5M | $30.6M | ||
| Q4 24 | $57.5M | $26.4M | ||
| Q3 24 | $51.5M | $23.8M | ||
| Q2 24 | $46.6M | $28.5M | ||
| Q1 24 | $44.9M | $29.6M |
| Q4 25 | $-44.1M | $-16.3M | ||
| Q3 25 | $-5.5M | $-2.1M | ||
| Q2 25 | $-5.6M | $-9.5M | ||
| Q1 25 | $-11.4M | $-8.6M | ||
| Q4 24 | $9.6M | $-9.3M | ||
| Q3 24 | $941.0K | $-28.1M | ||
| Q2 24 | $-10.4M | $-7.8M | ||
| Q1 24 | $-6.2M | $-7.4M |
| Q4 25 | 52.9% | 35.0% | ||
| Q3 25 | 52.7% | 39.9% | ||
| Q2 25 | 52.3% | 33.2% | ||
| Q1 25 | 48.6% | 39.8% | ||
| Q4 24 | 58.5% | 40.3% | ||
| Q3 24 | 56.3% | 13.2% | ||
| Q2 24 | 54.6% | 34.1% | ||
| Q1 24 | 51.3% | 37.0% |
| Q4 25 | -9.0% | -39.6% | ||
| Q3 25 | -17.6% | -4.8% | ||
| Q2 25 | -23.3% | -27.5% | ||
| Q1 25 | -36.1% | -29.5% | ||
| Q4 24 | 5.2% | -37.6% | ||
| Q3 24 | -8.2% | -121.4% | ||
| Q2 24 | -18.3% | -30.3% | ||
| Q1 24 | -23.9% | -28.5% |
| Q4 25 | -70.9% | -34.9% | ||
| Q3 25 | -10.5% | -4.1% | ||
| Q2 25 | -12.2% | -26.5% | ||
| Q1 25 | -27.5% | -28.1% | ||
| Q4 24 | 16.8% | -35.4% | ||
| Q3 24 | 1.8% | -118.0% | ||
| Q2 24 | -22.4% | -27.2% | ||
| Q1 24 | -13.8% | -24.9% |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.13 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | — | $-0.39 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $53.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $96.0M |
| Total Assets | $461.5M | $139.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $53.2M | ||
| Q3 25 | $93.3M | $59.0M | ||
| Q2 25 | $75.5M | $57.0M | ||
| Q1 25 | $95.3M | $57.8M | ||
| Q4 24 | $98.7M | $54.6M | ||
| Q3 24 | $162.3M | $69.8M | ||
| Q2 24 | $177.9M | $80.1M | ||
| Q1 24 | $168.8M | $93.9M |
| Q4 25 | $341.7M | $96.0M | ||
| Q3 25 | $378.6M | $119.7M | ||
| Q2 25 | $377.6M | $118.4M | ||
| Q1 25 | $379.6M | $126.1M | ||
| Q4 24 | $395.7M | $127.1M | ||
| Q3 24 | $385.5M | $129.5M | ||
| Q2 24 | $389.1M | $149.1M | ||
| Q1 24 | $392.6M | $154.4M |
| Q4 25 | $461.5M | $139.9M | ||
| Q3 25 | $494.9M | $164.3M | ||
| Q2 25 | $493.3M | $165.0M | ||
| Q1 25 | $482.6M | $158.1M | ||
| Q4 24 | $499.5M | $158.2M | ||
| Q3 24 | $491.2M | $166.3M | ||
| Q2 24 | $483.7M | $182.4M | ||
| Q1 24 | $492.1M | $195.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $8.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $8.0M |
| FCF MarginFCF / Revenue | -2.9% | 17.0% |
| Capex IntensityCapex / Revenue | 1.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $29.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $8.0M | ||
| Q3 25 | $-3.9M | $9.1M | ||
| Q2 25 | $108.0K | $7.0M | ||
| Q1 25 | $-125.0K | $6.1M | ||
| Q4 24 | $2.0M | $-10.5M | ||
| Q3 24 | $13.2M | $-7.1M | ||
| Q2 24 | $6.2M | $-8.0M | ||
| Q1 24 | $4.0M | $-350.0K |
| Q4 25 | $-1.8M | $8.0M | ||
| Q3 25 | $-4.6M | $8.7M | ||
| Q2 25 | $-1.5M | $6.8M | ||
| Q1 25 | $-974.0K | $6.0M | ||
| Q4 24 | $1.1M | $-12.4M | ||
| Q3 24 | $12.2M | $-7.1M | ||
| Q2 24 | $5.2M | $-8.2M | ||
| Q1 24 | $3.4M | $-447.0K |
| Q4 25 | -2.9% | 17.0% | ||
| Q3 25 | -8.7% | 16.9% | ||
| Q2 25 | -3.2% | 19.0% | ||
| Q1 25 | -2.3% | 19.5% | ||
| Q4 24 | 1.9% | -47.0% | ||
| Q3 24 | 23.7% | -30.0% | ||
| Q2 24 | 11.0% | -28.9% | ||
| Q1 24 | 7.6% | -1.5% |
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 1.3% | 0.9% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 2.0% | 0.4% | ||
| Q4 24 | 1.6% | 7.1% | ||
| Q3 24 | 2.0% | 0.2% | ||
| Q2 24 | 2.3% | 0.8% | ||
| Q1 24 | 1.3% | 0.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
TLS
| Security Solutions Segment | $44.8M | 96% |
| Secure Networks Segment | $1.9M | 4% |
